NCT03008785

Brief Summary

This study evaluate if 10 weeks of mixed exercise combined with isoflavones could have greater effects on climacteric symptoms, body composition and hydratation, lipidic and inflamatory profile than exercise alone in postmenopausal women. the participants will be randomly assigned to the group: placebo and exercise or 100mg of isoflavone and exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

December 28, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 2, 2017

Completed
Last Updated

February 20, 2019

Status Verified

February 1, 2019

Enrollment Period

1.4 years

First QC Date

December 28, 2016

Last Update Submit

February 19, 2019

Conditions

Keywords

isoflavoneblood pressureclimateric symptomsexercise

Outcome Measures

Primary Outcomes (1)

  • Change in blood pressure

    Evaluate change in blood pressure through ambulatory 24-hour blood pressure monitoring used before the begin of intervention and after 10 weeks.

    Change in blood pressure in 10 weeks intervention

Secondary Outcomes (10)

  • Climateric Symptoms (Kupperman-Blatt Index)

    before and after 10 weeks

  • Climateric Symptoms (Cervantes Scale)

    before the begin the intervention and after 10 weeks

  • Climateric Symptoms (Menopause Rating Scale)

    before and after 10 weeks

  • Lipid profile (enzymatic colorimetric method)

    before and after 10 weeks

  • Human cytokines (Flow Cytometry)

    before and after 10 weeks

  • +5 more secondary outcomes

Study Arms (2)

group isoflavone and exercise

EXPERIMENTAL

The isoflavone group received daily 100mg of isoflavones.

Other: exerciseOther: isoflavone

group placebo and exercise

EXPERIMENTAL

The placebo group received 100mg containing starch of corn.

Other: exerciseOther: Placebo

Interventions

The training program consisted of aerobic and resisted combined physical exercises performed during 10 weeks, three times weekly with 45 minutes sessions: 5 minutes of warm-up on treadmill, 20 minutes of aerobic exercises and 20 minutes of resistance exercises.

group isoflavone and exercisegroup placebo and exercise

Daily supplementation in 1 capsule per day of 100mg of isoflavones (containing 3.3% genistein, 93.5% dadzein and 3.2% glycitein).

group isoflavone and exercise
PlaceboOTHER

Daily supplementation in 1 capsule per day containing starch of corn.

group placebo and exercise

Eligibility Criteria

Age50 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy postmenopausal woman
  • to be able to practice exercises on treadmill and weight exercises
  • without physical complications that prevent the execution of physical exercises
  • have no history of cardiovascular disease, diabetes, renal pathologies or hypertension

You may not qualify if:

  • smokers
  • use hormone therapy or isoflavone
  • use drugs that interfere with lipid and antihypertensive metabolism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guilherme Morais Puga

Uberlândia, Minas Gerais, 38400-678, Brazil

Location

Related Publications (3)

  • Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism. 2015 Feb;64(2):236-43. doi: 10.1016/j.metabol.2014.09.005. Epub 2014 Oct 5.

    PMID: 25441251BACKGROUND
  • Lebon J, Riesco E, Tessier D, Dionne IJ. Additive effects of isoflavones and exercise training on inflammatory cytokines and body composition in overweight and obese postmenopausal women: a randomized controlled trial. Menopause. 2014 Aug;21(8):869-75. doi: 10.1097/GME.0000000000000177.

  • Barbosa CD, Costa JG, Giolo JS, Rossato LT, Nahas PC, Mariano IM, Batista JP, Puga GM, de Oliveira EP. Isoflavone supplementation plus combined aerobic and resistance exercise do not change phase angle values in postmenopausal women: A randomized placebo-controlled clinical trial. Exp Gerontol. 2019 Mar;117:31-37. doi: 10.1016/j.exger.2018.08.007. Epub 2018 Sep 1.

MeSH Terms

Conditions

Motor Activity

Interventions

ExerciseIsoflavones

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaFlavonoidsChromonesBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Guilherme Puga, PhD

    Federal University of Uberlandia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Guilherme Morais Puga PhD

Study Record Dates

First Submitted

December 28, 2016

First Posted

January 2, 2017

Study Start

February 1, 2015

Primary Completion

July 1, 2016

Study Completion

December 1, 2016

Last Updated

February 20, 2019

Record last verified: 2019-02

Locations